Joan Miquell Nolla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joan Miquell Nolla has a total of 347 co-authors. Here are the top co-authors by number of shared publications:
- Javier Narváez
Department of Rheumatology, Hospital Universitario de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Faculty of Medicine and Health Sciences, Universitat de Barcelona (UB), Barcelona, Spain
32 shared publications - Carmen Gómez-Vaquero
Department of Rheumatology, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, 08907 Barcelona, Spain
19 shared publications - Diego Benavent
Department of Rheumatology, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, 08907 Barcelona, Spain
12 shared publications - Laura Berbel-Arcobé
Department of Rheumatology, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, 08907 Barcelona, Spain
12 shared publications - Paola Vidal-Montal
Department of Rheumatology, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, 08907 Barcelona, Spain
12 shared publications - Lidia Valencia-Muntalà
Department of Rheumatology, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, 08907 Barcelona, Spain
11 shared publications
Latest Publications
- 13 November 2026
- Published by Oxford University Press (OUP) in Rheumatology
Hyperuricemia, disease activity, and 10-year cardiovascular risk in chronic inflammatory arthritis: a post-hoc analysis of the CARMA project
Objectives: To determine the prognostic impact of hyperuricemia on cardiovascular events and its association with inflammatory markers and disease activity in patients with chronic inflammatory arthritis (CIA). Methods: Post-hoc analysis of a 10-year prospective cohort (2010-2022) including 1,552 patients with CIA and 349 controls from 67 Spanish hospitals. Hyperuricemia was defined as serum urate (SU) >6.8 mg/dL at baseline, and its impact on major adverse cardiovascular events (MACE) during follow-up was assessed using multivariable logistic regression. Associations of hyperuricemia and SU levels with inflammatory markers and individual (swollen joint count, tender joint count, global VAS) and composite disease activity indices (DAS28, BASDAI) were analyzed using Pearson correlation and Mann-Whitney U test. Results: Hyperuricemia prevalence was 11.2% in both CIA and controls, with a mean serum urate level of 5.0 ± 2.3 in the CIA group and 5.0 ± 1.4 in controls. Hyperuricemia independently increased the risk of MACE in CIA (adjusted OR 1.87, 95% CI 1.23-2.86), particularly in axial spondyloarthritis (adjusted OR 4.02, 95% CI 1.96-8.24), but not in rheumatoid arthritis or psoriatic arthritis; SU levels were not predictive. Hyperuricemia correlated with higher hsCRP levels in axial spondyloarthritis, psoriatic arthritis, and controls, but not in rheumatoid arthritis. No associations were found with ESR or disease activity indices. Conclusion: Baseline hyperuricemia is an independent prognostic factor for cardiovascular events in CIA, particularly in axial spondyloarthritis, but not in non-inflammatory controls. It was also associated with higher hsCRP levels, without any effect on disease activity indices. Individualized management strategies are needed in CIA.
- 13 November 2026
- Published by Oxford University Press (OUP) in Rheumatology
Hyperuricemia, disease activity, and 10-year cardiovascular risk in chronic inflammatory arthritis: a post-hoc analysis of the CARMA project
Objectives: To determine the prognostic impact of hyperuricemia on cardiovascular events and its association with inflammatory markers and disease activity in patients with chronic inflammatory arthritis (CIA). Methods: Post-hoc analysis of a 10-year prospective cohort (2010-2022) including 1,552 patients with CIA and 349 controls from 67 Spanish hospitals. Hyperuricemia was defined as serum urate (SU) >6.8 mg/dL at baseline, and its impact on major adverse cardiovascular events (MACE) during follow-up was assessed using multivariable logistic regression. Associations of hyperuricemia and SU levels with inflammatory markers and individual (swollen joint count, tender joint count, global VAS) and composite disease activity indices (DAS28, BASDAI) were analyzed using Pearson correlation and Mann-Whitney U test. Results: Hyperuricemia prevalence was 11.2% in both CIA and controls, with a mean serum urate level of 5.0 ± 2.3 in the CIA group and 5.0 ± 1.4 in controls. Hyperuricemia independently increased the risk of MACE in CIA (adjusted OR 1.87, 95% CI 1.23-2.86), particularly in axial spondyloarthritis (adjusted OR 4.02, 95% CI 1.96-8.24), but not in rheumatoid arthritis or psoriatic arthritis; SU levels were not predictive. Hyperuricemia correlated with higher hsCRP levels in axial spondyloarthritis, psoriatic arthritis, and controls, but not in rheumatoid arthritis. No associations were found with ESR or disease activity indices. Conclusion: Baseline hyperuricemia is an independent prognostic factor for cardiovascular events in CIA, particularly in axial spondyloarthritis, but not in non-inflammatory controls. It was also associated with higher hsCRP levels, without any effect on disease activity indices. Individualized management strategies are needed in CIA.
- Open Access
- 14 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7133
Beyond Disease Activity: Fatigue and Health-Related Quality of Life in Rheumatoid Arthritis Remission and Low Disease Activity
Background/Objectives: Remission and low disease activity (LDA) are established treatment targets in rheumatoid arthritis (RA), but they may not imply normalization of patient-perceived disease burden. Fatigue and health-related quality of life (HRQoL) provide complementary measures of patient-perceived health beyond inflammatory disease activity. Moreover, disease activity states defined by the Disease Activity Score in 28 joints (DAS28) and the Routine Assessment of Patient Index Data 3 (RAPID3) may be associated with different patient-reported outcome profiles. We aimed to compare fatigue and HRQoL in patients with RA classified as being in remission or LDA with those of controls and to assess agreement between DAS28 and RAPID3 classifications. Methods: We conducted a cross-sectional comparative study with a control group within the BELL-RA-LIFE cohort including 275 patients with RA aged >50 years and 300 controls with a comparable age and sex distribution. Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) and HRQoL using the Short Form-12 Physical (PCS) and Mental Component Summary (MCS) scores. Patients were classified independently according to DAS28 and RAPID3. Multivariable linear regression models adjusted for age, sex, body mass index, and hemoglobin were used to estimate differences versus controls. Agreement between DAS28 and RAPID3 was assessed using weighted Cohen’s kappa. Results: No statistically significant differences from controls were detected in FACIT-F or MCS scores among patients in DAS28 remission, although PCS scores were lower (adjusted difference −3.37, 95% CI −5.56 to −1.18; nominal p = 0.003; Holm-adjusted p = 0.033). DAS28-defined LDA was associated with greater fatigue and poorer PCS scores, although these differences did not remain statistically significant after Holm adjustment (adjusted p = 0.256 and p = 0.100, respectively), whereas MCS scores remained significantly lower (adjusted difference −5.15, 95% CI −8.14 to −2.15; nominal p = 0.001; adjusted p = 0.012). In patients in RAPID3 remission, PCS and MCS scores did not differ significantly from controls, while FACIT-F scores were higher; this difference did not remain statistically significant after Holm adjustment (adjusted p = 0.117); no statistically significant differences were detected for RAPID3-defined LDA across the three outcomes. Overall agreement between DAS28 and RAPID3 was limited (quadratic weighted κ = 0.35, 95% CI 0.26–0.44), with no significant difference between women and men (κ = 0.30 and 0.41, respectively; Δκ = 0.11, 95% CI −0.12 to 0.31; p = 0.34). RAPID3 more frequently classified patients into higher disease activity categories than DAS28 in 80.6% of discordant classifications. Conclusions: Remission and LDA in RA were associated with different residual health burdens when assessed using DAS28. Patients in DAS28 remission had significantly lower physical HRQoL than controls, while those in DAS28-defined LDA had significantly poorer mental HRQoL. No statistically significant differences in fatigue or HRQoL were observed for RAPID3-defined remission or LDA. Agreement between DAS28 and RAPID3 was limited and directional, with RAPID3 more frequently assigning patients to higher disease activity categories. These findings support the complementary assessment of inflammatory disease activity and patient-reported health in patients with RA.
- 14 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7133
Open AccessBeyond Disease Activity: Fatigue and Health-Related Quality of Life in Rheumatoid Arthritis Remission and Low Disease Activity
Background/Objectives: Remission and low disease activity (LDA) are established treatment targets in rheumatoid arthritis (RA), but they may not imply normalization of patient-perceived disease burden. Fatigue and health-related quality of life (HRQoL) provide complementary measures of patient-perceived health beyond inflammatory disease activity. Moreover, disease activity states defined by the Disease Activity Score in 28 joints (DAS28) and the Routine Assessment of Patient Index Data 3 (RAPID3) may be associated with different patient-reported outcome profiles. We aimed to compare fatigue and HRQoL in patients with RA classified as being in remission or LDA with those of controls and to assess agreement between DAS28 and RAPID3 classifications. Methods: We conducted a cross-sectional comparative study with a control group within the BELL-RA-LIFE cohort including 275 patients with RA aged >50 years and 300 controls with a comparable age and sex distribution. Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) and HRQoL using the Short Form-12 Physical (PCS) and Mental Component Summary (MCS) scores. Patients were classified independently according to DAS28 and RAPID3. Multivariable linear regression models adjusted for age, sex, body mass index, and hemoglobin were used to estimate differences versus controls. Agreement between DAS28 and RAPID3 was assessed using weighted Cohen’s kappa. Results: No statistically significant differences from controls were detected in FACIT-F or MCS scores among patients in DAS28 remission, although PCS scores were lower (adjusted difference −3.37, 95% CI −5.56 to −1.18; nominal p = 0.003; Holm-adjusted p = 0.033). DAS28-defined LDA was associated with greater fatigue and poorer PCS scores, although these differences did not remain statistically significant after Holm adjustment (adjusted p = 0.256 and p = 0.100, respectively), whereas MCS scores remained significantly lower (adjusted difference −5.15, 95% CI −8.14 to −2.15; nominal p = 0.001; adjusted p = 0.012). In patients in RAPID3 remission, PCS and MCS scores did not differ significantly from controls, while FACIT-F scores were higher; this difference did not remain statistically significant after Holm adjustment (adjusted p = 0.117); no statistically significant differences were detected for RAPID3-defined LDA across the three outcomes. Overall agreement between DAS28 and RAPID3 was limited (quadratic weighted κ = 0.35, 95% CI 0.26–0.44), with no significant difference between women and men (κ = 0.30 and 0.41, respectively; Δκ = 0.11, 95% CI −0.12 to 0.31; p = 0.34). RAPID3 more frequently classified patients into higher disease activity categories than DAS28 in 80.6% of discordant classifications. Conclusions: Remission and LDA in RA were associated with different residual health burdens when assessed using DAS28. Patients in DAS28 remission had significantly lower physical HRQoL than controls, while those in DAS28-defined LDA had significantly poorer mental HRQoL. No statistically significant differences in fatigue or HRQoL were observed for RAPID3-defined remission or LDA. Agreement between DAS28 and RAPID3 was limited and directional, with RAPID3 more frequently assigning patients to higher disease activity categories. These findings support the complementary assessment of inflammatory disease activity and patient-reported health in patients with RA.
- 8 September 2026
- Published by Elsevier in Autoimmunity Reviews
- Vol. 25 (12) , 104184
Characterizing systemic lupus erythematosus associated myocarditis: From rare clinical disease to subclinical involvement
- 8 September 2026
- Published by Elsevier in Autoimmunity Reviews
- Vol. 25 (12) , 104184
Characterizing systemic lupus erythematosus associated myocarditis: From rare clinical disease to subclinical involvement
- Open Access
- 2 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (11) , 4305
Fatigue in Middle-Aged and Older Adults with Axial Spondyloarthritis: A Sex-Stratified Case–Control Study
Background: Fatigue is a common and disabling symptom in axial spondyloarthritis (axSpA), yet its magnitude relative to the general population and potential sex-specific differences remain insufficiently characterized, particularly in older adults. We therefore aimed to assess fatigue in adults aged ≥ 50 years with axSpA, using the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT-F) scale, to compare fatigue levels with age- and sex-matched controls, and to explore sex-specific differences and clinical factors associated with fatigue. Methods: We conducted an observational case–control study including consecutive patients with axSpA aged ≥ 50 years and control subjects frequency-matched by age and sex. Fatigue was assessed using the FACIT-F, and clinically relevant fatigue was defined as a FACIT-F score < 40. Case–control comparisons were stratified by sex, and sex-stratified multivariable linear regression models were applied. Results: The study included 173 patients with axSpA (120 men, 53 women; mean age: 64.2 years) and 383 controls. Clinically relevant fatigue was more frequent in women than in men (84.9% vs. 50.0%; p < 0.001). Women reported more severe fatigue than men (FACIT-F: 29.4 ± 10.4 vs. 37.4 ± 10.2; p < 0.001). In case–control comparisons, fatigue was greater in patients than in controls in both sexes, with descriptively larger differences among women. In sex-stratified multivariable analyses, the ASAS Health Index (ASAS-HI) was independently associated with fatigue in both men and women. In reduced models including age, BASDAI, and ASAS-HI, ASAS-HI remained independently associated with FACIT-F in both men (β: −1.74, 95% CI: −2.08 to −1.41) and women (β: −1.80, 95% CI: −2.35 to −1.26; p < 0.001 for both). BASDAI showed an additional independent association in women (β: −1.19, 95%: CI −2.09 to −0.30; p = 0.010), but not in men. Conclusions: Fatigue is highly prevalent and clinically relevant in adults aged ≥50 years with axSpA, with a clear sex-specific pattern. Women experience a greater fatigue burden, and comparisons with controls suggest a larger excess among women. Fatigue represents an important dimension of disease burden in axSpA, with stronger associations with overall health status than with conventional inflammatory measures.
- 2 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (11) , 4305
Open AccessFatigue in Middle-Aged and Older Adults with Axial Spondyloarthritis: A Sex-Stratified Case–Control Study
Background: Fatigue is a common and disabling symptom in axial spondyloarthritis (axSpA), yet its magnitude relative to the general population and potential sex-specific differences remain insufficiently characterized, particularly in older adults. We therefore aimed to assess fatigue in adults aged ≥ 50 years with axSpA, using the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT-F) scale, to compare fatigue levels with age- and sex-matched controls, and to explore sex-specific differences and clinical factors associated with fatigue. Methods: We conducted an observational case–control study including consecutive patients with axSpA aged ≥ 50 years and control subjects frequency-matched by age and sex. Fatigue was assessed using the FACIT-F, and clinically relevant fatigue was defined as a FACIT-F score < 40. Case–control comparisons were stratified by sex, and sex-stratified multivariable linear regression models were applied. Results: The study included 173 patients with axSpA (120 men, 53 women; mean age: 64.2 years) and 383 controls. Clinically relevant fatigue was more frequent in women than in men (84.9% vs. 50.0%; p < 0.001). Women reported more severe fatigue than men (FACIT-F: 29.4 ± 10.4 vs. 37.4 ± 10.2; p < 0.001). In case–control comparisons, fatigue was greater in patients than in controls in both sexes, with descriptively larger differences among women. In sex-stratified multivariable analyses, the ASAS Health Index (ASAS-HI) was independently associated with fatigue in both men and women. In reduced models including age, BASDAI, and ASAS-HI, ASAS-HI remained independently associated with FACIT-F in both men (β: −1.74, 95% CI: −2.08 to −1.41) and women (β: −1.80, 95% CI: −2.35 to −1.26; p < 0.001 for both). BASDAI showed an additional independent association in women (β: −1.19, 95%: CI −2.09 to −0.30; p = 0.010), but not in men. Conclusions: Fatigue is highly prevalent and clinically relevant in adults aged ≥50 years with axSpA, with a clear sex-specific pattern. Women experience a greater fatigue burden, and comparisons with controls suggest a larger excess among women. Fatigue represents an important dimension of disease burden in axSpA, with stronger associations with overall health status than with conventional inflammatory measures.
- 27 March 2026
- Published by Elsevier in Autoimmunity Reviews
- Vol. 25 (5) , 104041
Prevalence and clinical significance of anti–NOR90 antibodies in systemic sclerosis: Results from a multicentre cohort and systematic literature review
- 27 March 2026
- Published by Elsevier in Autoimmunity Reviews
- Vol. 25 (5) , 104041
Prevalence and clinical significance of anti–NOR90 antibodies in systemic sclerosis: Results from a multicentre cohort and systematic literature review
- Open Access
- 21 March 2026
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 28
Beyond glomeruli: interstitial fibrosis and tubular atrophy predict poor renal outcomes in lupus nephritis
To evaluate the prevalence, associated factors, and prognostic performance of NIH activity index–defined interstitial inflammation (NIH-TII) and interstitial fibrosis and tubular atrophy (IFTA) in lupus nephritis (LN). This retrospective cohort study analyzed 195 renal biopsy episodes from 135 LN patients. Tubulointerstitial lesions were graded according to histopathological severity. NIH-TII was assessed semiquantitatively using the interstitial inflammation component of the modified NIH activity index. Among 195 renal biopsies, class IV LN was most frequent (49.2%). Tubulointerstitial involvement was present in 74.3% of cases, with isolated NIH-TII in 14.4%, isolated IFTA in 15.9%, and both in 44.1%. Moderate-to-severe NIH-TII and IFTA were observed in 11.3% and 15.9% of biopsies, respectively. Patients with moderate-to-severe NIH-TII were older, had worse renal function, and more frequently exhibited moderate-to-severe IFTA. Moderate-to-severe IFTA was associated with older age, longer SLE duration, prior LN episodes, higher chronicity index, and impaired renal function, and was strongly associated with non-renal response and ESRD progression. In multivariable logistic regression, prior LN episodes (OR 8.4) and moderate-to-severe IFTA (OR 4.92) predicted non-renal response. In multivariable Cox regression, prior LN episodes (HR 8.55), moderate-to-severe IFTA (HR 8.93), and thrombotic microangiopathy (HR 12.99) predicted ESRD progression. Longitudinal analyses showed frequent progression of IFTA over time with increasing chronicity index. Moderate-to-severe IFTA was a strong predictor of renal non-response and ESRD progression. TII defined according to the NIH activity index, which does not include systematic assessment of tubulitis or total cortical inflammatory burden, was not independently associated with outcomes. The online version contains supplementary material available at 10.1186/s13075-026-03799-6.
- 21 March 2026
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 28
Open AccessBeyond glomeruli: interstitial fibrosis and tubular atrophy predict poor renal outcomes in lupus nephritis
To evaluate the prevalence, associated factors, and prognostic performance of NIH activity index–defined interstitial inflammation (NIH-TII) and interstitial fibrosis and tubular atrophy (IFTA) in lupus nephritis (LN). This retrospective cohort study analyzed 195 renal biopsy episodes from 135 LN patients. Tubulointerstitial lesions were graded according to histopathological severity. NIH-TII was assessed semiquantitatively using the interstitial inflammation component of the modified NIH activity index. Among 195 renal biopsies, class IV LN was most frequent (49.2%). Tubulointerstitial involvement was present in 74.3% of cases, with isolated NIH-TII in 14.4%, isolated IFTA in 15.9%, and both in 44.1%. Moderate-to-severe NIH-TII and IFTA were observed in 11.3% and 15.9% of biopsies, respectively. Patients with moderate-to-severe NIH-TII were older, had worse renal function, and more frequently exhibited moderate-to-severe IFTA. Moderate-to-severe IFTA was associated with older age, longer SLE duration, prior LN episodes, higher chronicity index, and impaired renal function, and was strongly associated with non-renal response and ESRD progression. In multivariable logistic regression, prior LN episodes (OR 8.4) and moderate-to-severe IFTA (OR 4.92) predicted non-renal response. In multivariable Cox regression, prior LN episodes (HR 8.55), moderate-to-severe IFTA (HR 8.93), and thrombotic microangiopathy (HR 12.99) predicted ESRD progression. Longitudinal analyses showed frequent progression of IFTA over time with increasing chronicity index. Moderate-to-severe IFTA was a strong predictor of renal non-response and ESRD progression. TII defined according to the NIH activity index, which does not include systematic assessment of tubulitis or total cortical inflammatory burden, was not independently associated with outcomes. The online version contains supplementary material available at 10.1186/s13075-026-03799-6.
- Open Access
- 27 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1821
Health-Related Quality of Life in Older Adults with Rheumatoid Arthritis: A Sex-Specific Case–Control Analysis of Physical and Mental Health Domains
Background: The impact of rheumatoid arthritis (RA) on health-related quality of life (HRQoL) in older adults remains incompletely characterized, particularly regarding sex-specific patterns and the relative contribution of physical and mental health domains in later life. Methods: We conducted an observational cross-sectional case–control analysis including adults aged ≥65 years. A total of 180 patients with RA (65.6% women) were compared with 195 age- and sex-matched control subjects. HRQoL was assessed using the Short Form-12 (SF-12) questionnaire, generating Physical Component Summary (PCS) and Mental Component Summary (MCS) scores. Analyses were stratified by sex. Associations between HRQoL domains and clinical variables were examined using correlation analyses and sex-specific multivariable linear regression models. Effect sizes (Cohen’s d) were calculated to quantify the magnitude of between-group differences. Results: Women with RA showed significantly lower SF-12 physical (PCS) and mental (MCS) component scores than men with RA, indicating a greater impairment in overall HRQoL. Women also exhibited higher functional disability, as assessed by the Health Assessment Questionnaire (HAQ), and higher disease activity, as assessed by DAS28. In sex-stratified case–control comparisons, men with RA showed lower SF-12 PCS scores, while MCS scores were comparable to those of the age-matched male controls. In contrast, women with RA exhibited significantly lower PCS and MCS scores compared to age-matched female controls. In multivariable analyses, distinct sex-specific patterns were observed. In women with RA, HAQ emerged as the only independent determinant of PCS, whereas DAS28 was the sole independent determinant of MCS. In men with RA, PCS was independently associated with DAS28, whereas MCS was independently associated with HAQ. Effect size analyses indicated consistently small impairments in both physical and mental HRQoL domains in women, whereas in men, the impact was small and largely confined to the physical domain. Conclusions: In older adults with RA, HRQoL impairment is sex-dependent and domain-specific, with women experiencing a more pronounced and generalized reduction in both physical and mental health compared with men. Sex-specific differences in the relative contribution of disease activity and functional disability highlight the need for a differentiated interpretation of patient-reported outcomes in this population. A domain-specific and sex-aware assessment of HRQoL may enhance the clinical evaluation of older patients and provide a more comprehensive understanding of disease burden beyond inflammatory activity alone.
- 27 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1821
Open AccessHealth-Related Quality of Life in Older Adults with Rheumatoid Arthritis: A Sex-Specific Case–Control Analysis of Physical and Mental Health Domains
Background: The impact of rheumatoid arthritis (RA) on health-related quality of life (HRQoL) in older adults remains incompletely characterized, particularly regarding sex-specific patterns and the relative contribution of physical and mental health domains in later life. Methods: We conducted an observational cross-sectional case–control analysis including adults aged ≥65 years. A total of 180 patients with RA (65.6% women) were compared with 195 age- and sex-matched control subjects. HRQoL was assessed using the Short Form-12 (SF-12) questionnaire, generating Physical Component Summary (PCS) and Mental Component Summary (MCS) scores. Analyses were stratified by sex. Associations between HRQoL domains and clinical variables were examined using correlation analyses and sex-specific multivariable linear regression models. Effect sizes (Cohen’s d) were calculated to quantify the magnitude of between-group differences. Results: Women with RA showed significantly lower SF-12 physical (PCS) and mental (MCS) component scores than men with RA, indicating a greater impairment in overall HRQoL. Women also exhibited higher functional disability, as assessed by the Health Assessment Questionnaire (HAQ), and higher disease activity, as assessed by DAS28. In sex-stratified case–control comparisons, men with RA showed lower SF-12 PCS scores, while MCS scores were comparable to those of the age-matched male controls. In contrast, women with RA exhibited significantly lower PCS and MCS scores compared to age-matched female controls. In multivariable analyses, distinct sex-specific patterns were observed. In women with RA, HAQ emerged as the only independent determinant of PCS, whereas DAS28 was the sole independent determinant of MCS. In men with RA, PCS was independently associated with DAS28, whereas MCS was independently associated with HAQ. Effect size analyses indicated consistently small impairments in both physical and mental HRQoL domains in women, whereas in men, the impact was small and largely confined to the physical domain. Conclusions: In older adults with RA, HRQoL impairment is sex-dependent and domain-specific, with women experiencing a more pronounced and generalized reduction in both physical and mental health compared with men. Sex-specific differences in the relative contribution of disease activity and functional disability highlight the need for a differentiated interpretation of patient-reported outcomes in this population. A domain-specific and sex-aware assessment of HRQoL may enhance the clinical evaluation of older patients and provide a more comprehensive understanding of disease burden beyond inflammatory activity alone.
- Open Access
Nutritional Risk in Older Adults with Rheumatoid Arthritis: Sex-Specific Patterns and Clinical Implications of the Prognostic Nutritional Index
Background/Objectives: Nutritional risk is increasingly recognized as a relevant but under-assessed dimension of rheumatoid arthritis (RA), particularly in older adults managed in outpatient settings. Simple nutritional indices such as the Prognostic Nutritional Index (PNI) may help identify individuals at increased nutritional risk beyond conventional disease activity measures. This study aimed to characterize nutritional risk in older adults with RA using the Prognostic Nutritional Index, explore sex-specific patterns, and identify clinical associations of PNI variability, with complementary analyses focusing on high nutritional risk. Methods: We conducted an observational cross-sectional study including 275 consecutive adults aged ≥50 years with RA attending routine follow-up at a tertiary rheumatology clinic. Nutritional risk was assessed using the PNI, calculated from serum albumin and total lymphocyte count, and analyzed primarily as a continuous variable and secondarily using established cut-off values. Clinical characteristics, inflammatory markers, body mass index, laboratory parameters, and patient-reported outcomes were recorded. Analyses were stratified by sex. Multivariable linear regression models were used to identify factors associated with PNI variability, and complementary logistic regression analyses were performed to explore factors independently associated with high nutritional risk (PNI < 40). Results: More than half of the cohort (53.3%) exhibited PNI values compatible with nutritional risk. Men showed lower PNI values than women, with a markedly greater prevalence of high nutritional risk (18.0% vs. 5.0%, p < 0.001). In multivariable linear regression analyses, higher C-reactive protein levels and increasing age were independently associated with lower PNI values, whereas sex was not an independent determinant of PNI. In multivariable logistic regression analyses, increasing age and male sex were independently associated with high nutritional risk. In multivariable linear regression models restricted to men, hemoglobin emerged as the principal independent correlate of PNI. In complementary logistic regression analyses focusing on high nutritional risk (PNI < 40), hemoglobin remained the sole independent predictor (OR = 0.94, 95% CI 0.91–0.98; p < 0.01), supporting a robust association with clinically relevant nutritional risk. Conclusions: Nutritional risk assessed by the PNI is common among older adults with RA. Although sex does not independently determine PNI as a continuous measure, male sex is associated with severe nutritional risk. The PNI captures a clinically relevant dimension of disease burden that extends beyond joint inflammation and traditional activity indices, supporting its use as a pragmatic nutritional screening tool in routine rheumatology practice.
Open AccessNutritional Risk in Older Adults with Rheumatoid Arthritis: Sex-Specific Patterns and Clinical Implications of the Prognostic Nutritional Index
Background/Objectives: Nutritional risk is increasingly recognized as a relevant but under-assessed dimension of rheumatoid arthritis (RA), particularly in older adults managed in outpatient settings. Simple nutritional indices such as the Prognostic Nutritional Index (PNI) may help identify individuals at increased nutritional risk beyond conventional disease activity measures. This study aimed to characterize nutritional risk in older adults with RA using the Prognostic Nutritional Index, explore sex-specific patterns, and identify clinical associations of PNI variability, with complementary analyses focusing on high nutritional risk. Methods: We conducted an observational cross-sectional study including 275 consecutive adults aged ≥50 years with RA attending routine follow-up at a tertiary rheumatology clinic. Nutritional risk was assessed using the PNI, calculated from serum albumin and total lymphocyte count, and analyzed primarily as a continuous variable and secondarily using established cut-off values. Clinical characteristics, inflammatory markers, body mass index, laboratory parameters, and patient-reported outcomes were recorded. Analyses were stratified by sex. Multivariable linear regression models were used to identify factors associated with PNI variability, and complementary logistic regression analyses were performed to explore factors independently associated with high nutritional risk (PNI < 40). Results: More than half of the cohort (53.3%) exhibited PNI values compatible with nutritional risk. Men showed lower PNI values than women, with a markedly greater prevalence of high nutritional risk (18.0% vs. 5.0%, p < 0.001). In multivariable linear regression analyses, higher C-reactive protein levels and increasing age were independently associated with lower PNI values, whereas sex was not an independent determinant of PNI. In multivariable logistic regression analyses, increasing age and male sex were independently associated with high nutritional risk. In multivariable linear regression models restricted to men, hemoglobin emerged as the principal independent correlate of PNI. In complementary logistic regression analyses focusing on high nutritional risk (PNI < 40), hemoglobin remained the sole independent predictor (OR = 0.94, 95% CI 0.91–0.98; p < 0.01), supporting a robust association with clinically relevant nutritional risk. Conclusions: Nutritional risk assessed by the PNI is common among older adults with RA. Although sex does not independently determine PNI as a continuous measure, male sex is associated with severe nutritional risk. The PNI captures a clinically relevant dimension of disease burden that extends beyond joint inflammation and traditional activity indices, supporting its use as a pragmatic nutritional screening tool in routine rheumatology practice.
- Open Access
- 29 January 2026
- Published by MDPI AG in Preprints.org
Health-Related Quality of Life in Older Adults with Rheumatoid Arthritis: A Sex-Specific Case-Control Analysis of Physical and Mental Health Domains
Background: The impact of rheumatoid arthritis (RA) on health-related quality of life (HRQoL) in older adults remains incompletely characterized, particularly regarding sex-specific patterns and the relative contribution of physical and mental health domains in later life. Methods: We conducted an observational cross-sectional case–control analysis including adults aged ≥65 years. A total of 180 patients with RA (65.6% women) were compared with 195 age- and sex-matched control subjects. HRQoL was assessed using the Short Form-12 (SF-12) questionnaire, generating Physical Component Summary (PCS) and Mental Component Summary (MCS) scores. Analyses were stratified by sex. Associations between HRQoL domains and clinical variables were examined using correlation analyses and sex-specific multivariable linear regression models. Effect sizes (Cohen’s d) were calculated to quantify the magnitude of between-group differences. Results: Women with RA showed significantly lower SF-12 physical (PCS) and mental (MCS) component scores than men with RA, indicating a greater impairment in overall HRQoL. Women also exhibited higher functional disability, as assessed by the Health Assessment Questionnaire (HAQ), and higher disease activity, as assessed by DAS28. In sex-stratified case–control comparisons, men with RA showed SF-12 PCS and MCS scores comparable to those of age-matched male controls. In contrast, women with RA exhibited significantly lower PCS and MCS scores compared with age-matched female controls. In multivariable analyses, distinct sex-specific patterns were observed. In women with RA, HAQ emerged as the only independent determinant of PCS, whereas DAS28 was the sole independent determinant of MCS. In men with RA, PCS was independently associated with DAS28, whereas MCS was independently associated with HAQ. Effect size analyses indicated small-to-moderate impairments in both physical and mental HRQoL domains in women, whereas in men the impact was small and largely confined to the physical domain. Conclusions: In older adults with RA, HRQoL impairment is sex-dependent and domain-specific, with women experiencing a more pronounced and generalized reduction in both physical and mental health compared with men. Sex-specific differences in the relative contribution of disease activity and functional disability highlight the need for a differentiated interpretation of patient-reported outcomes in this population. A domain-specific and sex-aware assessment of HRQoL may enhance the clinical evaluation of older patients and provide a more comprehensive understanding of disease burden beyond inflammatory activity alone.
- 29 January 2026
- Published by MDPI AG in Preprints.org
Open AccessHealth-Related Quality of Life in Older Adults with Rheumatoid Arthritis: A Sex-Specific Case-Control Analysis of Physical and Mental Health Domains
Background: The impact of rheumatoid arthritis (RA) on health-related quality of life (HRQoL) in older adults remains incompletely characterized, particularly regarding sex-specific patterns and the relative contribution of physical and mental health domains in later life. Methods: We conducted an observational cross-sectional case–control analysis including adults aged ≥65 years. A total of 180 patients with RA (65.6% women) were compared with 195 age- and sex-matched control subjects. HRQoL was assessed using the Short Form-12 (SF-12) questionnaire, generating Physical Component Summary (PCS) and Mental Component Summary (MCS) scores. Analyses were stratified by sex. Associations between HRQoL domains and clinical variables were examined using correlation analyses and sex-specific multivariable linear regression models. Effect sizes (Cohen’s d) were calculated to quantify the magnitude of between-group differences. Results: Women with RA showed significantly lower SF-12 physical (PCS) and mental (MCS) component scores than men with RA, indicating a greater impairment in overall HRQoL. Women also exhibited higher functional disability, as assessed by the Health Assessment Questionnaire (HAQ), and higher disease activity, as assessed by DAS28. In sex-stratified case–control comparisons, men with RA showed SF-12 PCS and MCS scores comparable to those of age-matched male controls. In contrast, women with RA exhibited significantly lower PCS and MCS scores compared with age-matched female controls. In multivariable analyses, distinct sex-specific patterns were observed. In women with RA, HAQ emerged as the only independent determinant of PCS, whereas DAS28 was the sole independent determinant of MCS. In men with RA, PCS was independently associated with DAS28, whereas MCS was independently associated with HAQ. Effect size analyses indicated small-to-moderate impairments in both physical and mental HRQoL domains in women, whereas in men the impact was small and largely confined to the physical domain. Conclusions: In older adults with RA, HRQoL impairment is sex-dependent and domain-specific, with women experiencing a more pronounced and generalized reduction in both physical and mental health compared with men. Sex-specific differences in the relative contribution of disease activity and functional disability highlight the need for a differentiated interpretation of patient-reported outcomes in this population. A domain-specific and sex-aware assessment of HRQoL may enhance the clinical evaluation of older patients and provide a more comprehensive understanding of disease burden beyond inflammatory activity alone.
- Open Access
- 24 January 2026
- Published by Springer Nature in BMC Rheumatology
- Vol. 10 (1)
Self-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data
To assess the prevalence and persistence of self-reported depression and its associated factors in patients with systemic lupus erythematosus (SLE), using
- 24 January 2026
- Published by Springer Nature in BMC Rheumatology
- Vol. 10 (1)
Open AccessSelf-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data
To assess the prevalence and persistence of self-reported depression and its associated factors in patients with systemic lupus erythematosus (SLE), using